Development
GE HealthCare Technologies Inc.
GEHC
$71.62
$0.070.10%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -27.26% | -- | -- | -51.41% | -1.77% |
| Total Depreciation and Amortization | -8.28% | -- | -- | -1.26% | 1.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 725.49% | -- | -- | 204.65% | -304.00% |
| Change in Net Operating Assets | -51.83% | -- | -- | 308.11% | 150.66% |
| Cash from Operations | 0.77% | -- | -- | 0.00% | 9,572.73% |
| Capital Expenditure | -22.08% | -- | -- | -43.00% | -6.94% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | 200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 131.58% | -- | -- | 233.33% | -375.00% |
| Cash from Investing | 7.37% | -- | -- | -166.00% | 93.80% |
| Total Debt Issued | -100.17% | -- | -- | 99,900.00% | -- |
| Total Debt Repaid | -85,000.00% | -- | -- | -1,400.00% | 133.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.71% | -- | -- | -211.64% | -686.47% |
| Cash from Financing | -2,332.43% | -- | -- | 260.24% | -102.64% |
| Foreign Exchange rate Adjustments | -35.14% | -- | -- | 366.67% | 436.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -90.92% | -- | -- | 1,705.45% | 718.95% |